Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans
- 1 August 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (8) , 1665-1670
- https://doi.org/10.1161/01.atv.0000172632.96987.2d
Abstract
Objective— The participation of 5-lipoxygenase (5-LO) in the development of atherosclerosis has been suggested by recent studies. However, a role for 5-LO as a modulator of atherosclerotic plaque instability has not been previously reported in humans. Thus, the aims of this study was to analyze the expression of 5-LO in human carotid plaques and to investigate the mechanism by which this enzyme could lead to plaque instability and rupture. Methods and Results— We obtained atherosclerotic plaques from 60 patients undergoing carotid endarterectomy. We divided the plaques into symptomatic and symptomatic according to clinical evidence of plaque instability. Clinical evidence of plaque instability was provided by the assessment of recent ischemic symptoms attributable to the stenosis and by the presence of ipsilateral cerebral lesion(s) determined by computed tomography. Plaques were analyzed for CD68+ macrophages, CD3+ T cells, α-actin+ smooth muscle cells, 5-LO, cyclooxygenase 2, matrix metalloproteinase (MMP)-2, and MMP-9 by immunohistochemical, immunoblotting, and densitometric analyses. MMP activity was assessed by zymography. Leukotriene (LT) B4 and collagen were quantified by ELISA and Sirius red polarization, respectively. The percentage of macrophage-rich and T-cell–rich areas was larger in symptomatic compared with asymptomatic patients (25±6% versus 8±4%, P2, PPPPP4 production (18.15±3.56 versus 11.27±3.04 ng/g tissue, PConclusions— The expression of 5-LO is elevated in symptomatic compared with asymptomatic plaques and is associated with acute ischemic syndromes, possibly through the generation of LTB4, subsequent MMP biosynthesis, and plaque rupture. Plaque instability involves the participation of numerous genes, the most of which are still unknown. We conducted analyses of 5-lipoxygenase expression in human carotid plaques. 5-Lipoxygenase was overexpressed in symptomatic compared with asymptomatic plaques and correlated with increased leukotriene B4 and metalloproteinase production expression. Thus, this study indicates a potential role for 5-lipoxygenase in plaque instability.Keywords
This publication has 13 references indexed in Scilit:
- Blockade of the Angiotensin II Type 1 Receptor Stabilizes Atherosclerotic Plaques in Humans by Inhibiting Prostaglandin E 2 –Dependent Matrix Metalloproteinase ActivityCirculation, 2004
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and strokeNature Genetics, 2004
- Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and AtherosclerosisNew England Journal of Medicine, 2004
- The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic PlaquesCirculation, 2003
- Suppression of the Functionally Coupled Cyclooxygenase-2/Prostaglandin E Synthase as a Basis of Simvastatin-Dependent Plaque Stabilization in HumansCirculation, 2003
- Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesisProceedings of the National Academy of Sciences, 2003
- Modulation of Aspirin-Insensitive Eicosanoid Biosynthesis by 6-Methylprednisolone in Unstable AnginaCirculation, 2003
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development.Journal of Clinical Investigation, 1990